Unipharma Egypt

Pharmaceutical ManufacturingEgypt
Claim profile

More Information

Company size
201-500 employees
Headquarters
Egypt
Industry sectors
Pharmaceutical Manufacturing

About Unipharma Egypt

Who We Are

Egyptian Joint Stock Pharmaceutical Company is an Egyptian joint stock company established in 1997 under the investment laws of Egypt. The company began its first production in September 2001.

We manufacture a wide range of pharmaceutical dosage forms, including:

  • Tablets and capsules
  • Dry powder and hard gelatin capsules
  • Creams, gels, and ointments
  • Syrups, suspensions, and liquid veterinary solutions

We started with a portfolio of 13 products, including medicines such as Pono, Hepmarin, Parofen, and Univit, among others.

Our Mission

We are committed to providing high-quality healthcare and veterinary products along with reliable services that improve quality of life. We aim to serve both human and animal healthcare sectors in Egypt and beyond with safe and effective solutions.

Our Vision

Our vision is to become a leading healthcare company in the Middle East and Africa, ranking among the top pharmaceutical companies in the region within the coming years. We also aim to strengthen our position in veterinary medicine through continuous growth, innovation, and quality improvement.

Our Product Pipeline

We are continuously expanding our portfolio with products in key therapeutic areas, including:

  • Antibiotics
  • Antifungal medications
  • Antihypertensive drugs
  • Corticosteroids
  • Antidepressants
  • Vitamins (soft gelatin capsules)
  • Antiparasitic medicines

We remain focused on innovation and quality to meet the growing healthcare needs of patients and animals.